BT200 in Hereditary Bleeding Disorders
NCT04677803
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Von Willebrand Diseases
Hemophilia A
Interventions
DRUG:
BT200
Sponsor
Medical University of Vienna